Insys Therapeutics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2005
2006
2007
2008
2009
Sales/Revenue
542.70
11.00
0.00
0.00
0.00
Cost of Goods Sold (COGS) incl. D&A
1,301.90
1,154.00
651.00
174.00
135.00
Gross Income
759.20
1,143.00
651.00
174.00
135.00
SG&A Expense
41,972.20
34,182.00
13,082.00
8,968.00
6,374.00
EBIT
42,731.40
33,774.00
13,733.00
9,142.00
6,509.00
Unusual Expense
2,500.00
1,961.00
999.00
0.00
1,038.00
Non Operating Income/Expense
0.00
0.00
2,302.00
413.00
21.00
Interest Expense
0.00
0.00
0.00
85.00
152.00
Pretax Income
38,724.70
33,208.00
11,001.00
8,218.00
7,461.00
Income Tax
0.00
0.00
0.00
0.00
0.00
Equity in Affiliates
0.00
0.00
0.00
0.00
0.00
Consolidated Net Income
38,724.70
33,208.00
11,001.00
8,218.00
7,461.00
Net Income
38,724.70
33,208.00
11,001.00
8,218.00
7,461.00
Net Income After Extraordinaries
38,724.70
33,208.00
11,001.00
8,218.00
7,461.00
Net Income Available to Common
38,724.70
33,208.00
11,001.00
8,218.00
7,461.00
EPS (Basic)
1.64
1.20
0.39
0.29
0.26
Basic Shares Outstanding
23,601.60
27,782.10
28,264.70
28,492.50
28,498.80
EPS (Diluted)
1.64
1.20
0.39
0.29
0.26
Diluted Shares Outstanding
23,601.60
27,782.10
28,264.70
28,492.50
28,498.80
EBITDA
41,431.50
32,621.00
13,082.00
8,968.00
6,374.00
Other Operating Expense
0.00
1,551.00
0.00
0.00
0.00
Non-Operating Interest Income
1,506.70
2,527.00
1,429.00
596.00
217.00
Minority Interest Expense
0.00
0.00
0.00
0.00
0.00
Equity in Affiliates (Pretax)
0.00
0.00
0.00
0.00
0.00
Other After Tax Income (Expense)
0.00
0.00
0.00
0.00
0.00
Preferred Dividends
0.00
0.00
0.00
0.00
0.00
About Insys Therapeutics
View Profile
